Finnerty Thomas 4

4 · Anika Therapeutics, Inc. · Filed Mar 1, 2021

Form 4

Period: 2021-02-25

Chief Human Resources Officer

Transactions

Exercise/Conversion
Common Stock
2021-02-25+2,833→ 10,414 total
Tax Payment
Common Stock
2021-02-25$37.39/sh−832$31,108→ 9,582 total
Exercise/Conversion
Common Stock
2021-02-26+3,000→ 12,582 total
Tax Payment
Common Stock
2021-02-26$37.57/sh−881$33,099→ 11,701 total
Exercise/Conversion
Restricted Stock Unit
2021-02-26−3,000→ 3,000 total
Exercise: $0.00→ Common Stock (3,000 underlying)
Exercise/Conversion
Restricted Stock Unit
2021-02-25−2,833→ 5,667 total
Exercise: $0.00→ Common Stock (2,833 underlying)

Footnotes (8)

[F1]Reflects the first vesting installment of RSUs granted on February 25, 2020.
[F2]Reflects an aggregate of 832 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 25, 2021.
[F3]Reflects the closing price of the ANIK common stock on February 25, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
[F4]Reflects the second vesting installment of RSUs granted on February 26, 2019.
[F5]Reflects an aggregate of 881 shares of common stock retained by the Issuer to satisfy tax withholding obligations with respect to RSUs that vested on February 26, 2021.
[F6]Reflects the closing price of the ANIK common stock on February 26, 2021, the trading day on which the vesting of RSUs gave rise to tax withholding obligations.
[F7]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning February 25, 2021.
[F8]Each RSU represents the contingent right to receive one share of the Company's common stock. The RSUs vest in three equal annual installments beginning on February 26, 2020.

Documents

1 file